| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 48.729 | 578.714 | 1.319.997 | 2.366.464 | 3.204.400 |
| Total Income - EUR | - | - | - | - | - | 48.729 | 578.748 | 1.320.472 | 2.367.756 | 3.205.761 |
| Total Expenses - EUR | - | - | - | - | - | 36.490 | 535.213 | 1.266.263 | 2.188.703 | 3.041.770 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 12.239 | 43.534 | 54.210 | 179.053 | 163.991 |
| Net Profit/Loss - EUR | - | - | - | - | - | 10.777 | 37.972 | 44.527 | 144.480 | 123.367 |
| Employees | - | - | - | - | - | 0 | 5 | 10 | 16 | 26 |
Check the financial reports for the company - Organon Biosciences S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 42.104 | 29.904 | 31.054 | 24.320 |
| Current Assets | - | - | - | - | - | 63.772 | 354.293 | 715.938 | 1.016.596 | 1.527.465 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 54.469 | 234.759 | 691.390 | 708.765 | 1.019.807 |
| Cash | - | - | - | - | - | 9.303 | 119.534 | 24.548 | 307.831 | 507.659 |
| Shareholders Funds | - | - | - | - | - | 20.080 | 57.607 | 102.313 | 246.483 | 368.472 |
| Social Capital | - | - | - | - | - | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | - | - | - | - | - | 44.343 | 346.102 | 658.276 | 810.653 | 1.195.818 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Organon Biosciences S.r.l.